Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > B&B Conf - more confidence in next path?
View:
Post by Wino115 on Apr 28, 2022 12:59pm

B&B Conf - more confidence in next path?

At this price, the question is do you think Paul is more confident in the primary endpoint variables for 1a given it is likely to conclude sometime in the next 4 weeks? My hope is that by next week and certainly the annual, while they may not have final data, they may be more confident to hint at the two endpoints --that 300mg appears to be the likely dosage for initial trials (which we basically know), and what safety signals and pharmaco-data they may have seen around the final 6 patients is trending in the right direction. I'm not talking full blown data release, which we know can't happen until the end, but confident views around what they do know within reason.

They must understand and relate the poor valuation of the company to the uncertainty --or as Qwerty rightly called it, the darkeness before the dawn -- and if they can shed any new light around new data-based elements it behooves them to do so and to start to get the market thinking more positively about their project. This valuation should be an embarrasment for them and if it doesn't change, I assume the annual meeting won't be quite so pleasant despite the fact they will get affirmation on all their votes.  Let's see if we hear anything beyond what they said last quarter.
Comment by Wino115 on Apr 28, 2022 1:08pm
FYi, I think by today or tomorrow, we can be confident that the large seller should be fully cleared out if they were 30-50% of vols on all those days, even if they weren't that one large 100k share cross. This is a pure guesstimate and plenty of reasons for other buyers or sellers to move around, so take it with a grain of salt.  If those 100-200 share participation trades all day long ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities